loader image loader image
AGENDA Speakers VENUE


Brussels, Belgium - 22nd & 23rd May 2025

The Pharma Partnering Summit is an international event focused on Business Development & Licensing deals, R&D Collaborations, Investment & Fundraising, Alliances, M&A, as well as Deal-making Opportunities in the broader aspect within Pharma Biotech Ecosystem.

Register Now




Discover the Latest Trends, Products & Partners. Collaborate & Develop Your Business.

Pharma Biotech conference



Who will you meet?


Business Development & Licensing (BD&L) | Search & Evaluation | External Innovation | Alliance Management | Joint Ventures | Research Collaborations | Transactions M&A | Deal Sourcing | Buying Assets | Scientific Licensing | Technology Transfer | Financing | Investing | Raising Capital | Law & IP | Commercialisation

Pharma Partnering Summit Conference
Pharma Partnering Summit Conference
Pharma Partnering Summit Conference


Dealmaking Opportunities

(Pharma / Biotech)

 <h3>Pharma Partnering Summit Conference</h3>







Agenda Highlights



The agenda is structured for the needs of Pharma & Biotech Senior Executives. The EU Summit 2025 aims to help companies to expand their network by meeting Targeted Audience and put together deals to develop their business. Don't miss this opportunity and be a part of this excitng journey to create a healthier world by boosting Innovations through collaborations.

<h5>Pharma Partnering Summit Conference </h5>



Day 1 - 22nd May 2025

08:15 - 08:55 | Registration:
Selection of Coffee, Tea & Breakfast Pastries.
08:55 - 09:00 | Chairman's Address
09:00 - 09:15 | Keynote Presentation
09:15 - 09:45 | Panel Discussion 1:
Understanding and Satisfying Needs
When Negotiating a Deal
  • Valuation and Financial Structure: Balancing Risk and Reward.
  • Alignment of Strategic Interests: Identifying Mutual Objectives.
  • Cultural and Operational Synergy: Ensuring Smooth Collaboration.
  • Navigating Intellectual Property (IP) and Regulatory Considerations.
09:45 - 10:30 | Company Showcasing:
Presentations by Sponsoring Pharma Biotechs.
10:30 - 11:00 | Mid-Morning Coffee Break:
Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
11:00 - 11:30 | Panel Discussion 2:
Developing Trends & Therapeutic Areas to Watch
Build, Buy or Partner Where is The Money?
  • Investment Trends Shaping the Biopharma Landscape.
  • Emerging Therapeutic Areas: What’s Next in the Pipeline?
  • Build vs. Buy vs. Partner: Strategic Approaches to Growth.
  • Regulatory & Market Access Challenges, Navigating Success Pathways.
11:30 - 12:00 | Panel Discussion 3:
Deal Making Between Biotech & Big Pharma
What Each Side Should Know
  • Cultural Fit and Alignment of Values.
  • Best Practices for Due Diligence and Risk Assessment.
  • Communicating and Negotiating with Potential Partners.
  • Effective Strategies for Identifying and Selecting Partners.
12:00 - 13:00 | Company Showcasing:
Presentations by Sponsoring Pharma Biotechs.
13:10 - 14:00 | Lunch Break:
Hot Buffet Lunch will be Served.
16:00 - 16:30 | Afternoon Coffee Break:
Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
14:00 - 18:00 | Networking
Pre-Arranged One-2-One Meeting & Networking.

Day 2 - 23rd May 2025

08:30 - 08:55 | Registration:
Selection of Coffee, Tea & Breakfast Pastries.
08:55 - 09:00 | Chairman's Address
09:00 - 09:15 | Keynote Presentation
09:15 - 09:45 | Panel Discussion 4:
Partnering with Big Pharma
More Effective & Productive or Just More Complicated?
  • Access to Resources, Expertise, and Global Reach.
  • Bureaucracy, Decision-Making, and Cultural Differences.
  • Balancing Power Dynamics and Ensuring Equitable Partnerships.
  • Maximizing Innovation and Agility While Leveraging Capabilities.
09:45 - 10:30 | Company Showcasing:
Presentations by Sponsoring Pharma Biotechs.
10:30 - 11:00 | Mid-Morning Coffee Break:
Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
11:00 - 11:30 | Panel Discussion 5:
Best Practices in Structuring Deals
Preparing for When Things Go Well But Also When Things Go Wrong
  • Clearly Defined Exit Strategies.
  • Structuring Deals for Long Term Success and Flexibility.
  • Incorporating Contingency Mechanisms for Managing Risks.
  • Embedding Flexible Response Strategies to Address Changes.
11:30 - 12:00 | Panel Discussion 6:
Building Relationship Flexibility and Role Clarity
in Structuring Large & Small Company Deals
  • Avoiding Common Pitfalls in Role Definition and Flexibility.
  • Flexibility in Deal Structuring Without Compromising Core Objectives.
  • Communication/Governanc, Allowing Flexibility, Avoiding Role Confusion.
  • Define Roles & Responsibilities While Encouraging Adaptability.
12:00 - 13:00 | Company Showcasing:
Presentations by Sponsoring Pharma Biotechs.
13:10 - 14:00 | Lunch Break:
Hot Buffet Lunch will be Served.
15:30 - 16:00 | Afternoon Coffee Break:
Selection of Coffee, Tea, Soft Drinks & Assorted Snacks.
14:00 - 18:00 | Networking
Pre-Arranged One-2-One Meeting & Networking.


Previous Speakers



Speaker 1

Michael R Huebner

Director
Early Innovation Partnering

Johnson & Johnson

Speaker 2

Anna Jen

Director
Business Development

Roche

Speaker 3

Sergio Capancioni

Director
Search & Evaluation Int'l

AbbVie

Speaker 4

Kati Kaijasilta

Director
Business Development

Orion Corporation

Speaker 5

Alberto Borlacco

Head of Corporate Development

Chiesi Group

Speaker 6

Agnes Estes

Head of BD
& Strategic Partnerships

Novo Nordisk

Speaker 7

Julian Bertschinger

Global Head
External Innovation

Johnson & Johnson

Speaker 8

Romuald Laine

Head of Evaluation
and Partnering

Servier

Speaker 5

Holger Kissel

Vice President
Business Alliances

BioNTech

Speaker 6

Philip Hoffmann

Head Europe
BD&L

Daiichi-Sankyo

Speaker 7

Michel de Baar

Executive Director Europe
BD&L

MSD

Speaker 8

Oliver Kast

Global Head Oncology
BD&L

Boehringer Ingelheim

Speaker 5

Bradley Hardiman

Senior Director
Business Development

Astellas Pharma

Speaker 6

Ekaterine (Eka) Kortkhonjia

Senior Director
Early Innovation Partnering

Johnson & Johnson

Speaker 7

Chris Britten

Senior Vice President
Global Business Development

Grünenthal Group

Speaker 8

Loredana Ablondi

Head of Alliance Management

Chiesi Group





Company Showcasing:

Each showcasing participant will be allocated a 15-minute time slot for their company presentation. This opportunity enables participating companies to pitch their assets, services, platforms, technology, and solutions available for licensing or deal-making to a captivated audience of senior decision-makers. Presenting in this setting enhances your company’s visibility and increases the likelihood of engaging with qualified leads and potential partners. Additionally, this platform elevates brand awareness and strategically positions your company for future collaborations.

Exhibition:

Exhibiting participants will be provided with a dedicated tabletop space in the main networking hall. This prime location allows you to showcase your assets, services, solutions, technologies, and platforms using display materials for enhanced brand and asset visibility. During coffee and tea breaks, as well as dedicated networking sessions, the interactive setting of the networking hall fosters meaningful discussions, enabling you to engage with qualified leads and demonstrate the practical applications of your offerings, ultimately driving business growth.

One-to-One Partnering:

Two weeks before the event, all participants will be granted an access to our one-to-one online partnering platform. This platform enables you to search for and identify potential partners from the participant list, review their profiles and offerings, exchange information via a chat function, and send or receive meeting requests—all from a single, streamlined dashboard. Each day of the summit will include dedicated sessions for pre-arranged meetings and social networking, providing over 12 hours of opportunities to engage with decision-makers and explore potential partnerships.